Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 51
  • Journal CiteScore: 46.50
  • Journal Impact Factor: 26.99
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Abstract

Investigation of Darunavir resistance against triple mutant (V32I, I47V and V82I) in HIV-1 protease by molecular simulation approach

Rahul Jain, K. Ramanathan*

The HIV-1 Protease has been a critical drug target for war against AIDS and recently many protease inhibitors have been developed which inhibit the action of protease enzyme and prevent infection of HIV. However site-specific mutations occurring at one or more residues in HIV-1 protease has caused the development of resistance to protease inhibitors. In the present study, we have investigated the binding affinity of Darunavir to HIV-1 protease triple mutant (V32I, I47V and V82I) using bioinformatics approach. We have also highlighted the effect of mutations on the binding site residues and flap comprising residues in the HIV-1 protease by means of flexibility analysis. Molecular dockings were performed in order to gain insights into the binding mode of the Darunavir with HIV-1 protease structure. Subsequently, the docking results were also validated by means of PEARLS program. We hope that these results certainly will be helpful for the better understanding of mechanism of drug resistance.